NASDAQ: HCICHennessy Capital Investment Corp VIII Stock
$9.89+0.00 (+0%)
Updated May 21, 2026
HCIC Price
$9.89
Fair Value Price
$0.00
Market Cap
$351.23M
52 Week Low
$9.82
52 Week High
$10.05
P/E
N/A
P/B
-80.59x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.24
Operating Cash Flow
N/A
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HCIC Overview
Hennessy Capital Investment Corp. VIII focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses in technology industry. The company was incorporated in 2025 and is based in Zephyr Cove, Nevada.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HCIC's potential to beat the market
- HCIC doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
HCIC
RankedUnranked of 34
RankedUnranked of 34
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.80 | C | |
| $11.60 | C | |
| $10.32 | C |
Be the first to know about important HCIC news, forecast changes, insider trades & much more!
HCIC News
Overview
Due Diligence Score
–
Industry Average (7)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HCIC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HCIC ($9.89) is overvalued by 46,810,039.1% relative to our estimate of its Fair Value price of $0.00 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HCIC ($9.89) is not significantly undervalued (46,810,039.1%) relative to our estimate of its Fair Value price of $0.00 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HCIC's short-term assets ($989.16k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more HCIC due diligence checks available for Premium users.
Valuation
HCIC fair value
Fair Value of HCIC stock based on Discounted Cash Flow (DCF)
Price
$9.89
Fair Value
$0.00
Overvalued by
46,810,039.10%
HCIC ($9.89) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HCIC ($9.89) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HCIC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-80.59x
Industry
76.94x
HCIC's financial health
Profit margin
Revenue
$0.0
Net Income
$725.3k
Profit Margin
0%
Assets to liabilities
Assets
$243.7M
Liabilities
$5.4M
Debt to equity
-1.24
HCIC's short-term assets ($989.16k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HCIC's long-term liabilities ($5.27M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HCIC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HCIC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$522.2k
Investing
-$241.5M
Financing
$242.8M
HCIC vs Shell Company Stocks
Hennessy Capital Investment VIII Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.